Studies show FOXO4-DRI treatment reduces senescent cell markers including p16, p21, and senescence-associated -galactosidase activity by over 50% in expanded human chondrocytes at population doubling level 9 (PDL9), the stage typically used for clinical implantation
It is applied in the treatment of a wide range of tumors, most commonly in individual or combined therapies targeting cancers such as skin, breast, head and neck, lung, prostate, and bladder cancers [89]
Evidence suggests yesespecially for injury healing and gut health
It is not a scheduled controlled substance, so possession for personal research use is not criminalized the way a scheduled drug would be, but it also cannot be legally sold as a dietary supplement or marketed with a therapeutic claim
Research confirms that GHRP-6 produces a mild but measurable increase in cortisol with each injection